Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer

ClinicalTrials.gov ID: NCT01421472

Public ClinicalTrials.gov record NCT01421472. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 5:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Phase 2 Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To demonstrate whether addition of MM-121 to paclitaxel is more effective than treatment with paclitaxel alone, when administered as part of the neoadjuvant treatment in Her2 negative locally advanced operable breast cancer patients.

Study identification

NCT ID
NCT01421472
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Merrimack Pharmaceuticals
Industry
Enrollment
196 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2011
Primary completion
Nov 30, 2013
Completion
May 31, 2014
Last update posted
May 2, 2016

2011 – 2014

United States locations

U.S. sites
38
U.S. states
16
U.S. cities
35
Facility City State ZIP Site status
Universito of Birmingham atAlabama Birmingham Alabama 35294
Arizona Oncology Associates Tucson Arizona 85704
Arizona Oncology Associates Tuscon Arizona 85715
Marin Cancer Center Greenbrae California 94904
PMK Medical Group Oxnard California 93030
Wilshire Oncology Medical Group Rancho Cucamonga California 91730
Florida Cancer Research Institute Plantation Florida 33324
Piedmont Healthcare Altanta Georgia 30214
Piedmont Fayette Hospital Fayetteville Georgia 30214
Georgia Cancer Specialists Marietta Georgia 30341
University Of Chicago Chicago Illinois 60637
Illinois Cancer Specialists Niles Illinois 60714
Dana-Farber Cancer Institute Boston Massachusetts 02114
Dana Farber Cancer Institute Boston Massachusetts 02215
Beaumont Health Systems Royal Oak Michigan 48073
Comprehensive Cancer Centers of Nevada Henderson Nevada 89074
Cooper Cancer Institute Voorhees Township New Jersey 08043
University of New Mexico Cancer Center Albuquerque New Mexico 87106
Memorial Medical Center Las Cruces New Mexico 88011
Northwest Cancer Specialists Portland Oregon 97225
Cancer Center of the Carolinas Greenville South Carolina 29605
Texas Oncology - Amarillo Amarillo Texas 79106
Texas Oncology-Austin Central Austin Texas 78731
Texas Oncology - Bedford Bedford Texas 76022
Texas Oncology - Medical City Dallas Texas 75230
Texas Oncology - Dallas Dallas Texas 75231
Texas Oncology - Baylor Charles A Sammons Cancer Center Dallas Texas 75246
Texas Oncology -El Paso El Paso Texas 79902
Texas Oncology - Garland Garland Texas 75042
Texas Oncology - Memorial City Houston Texas 77024
Texas Oncology - Lewisville Lewisville Texas 75067
Texas Oncology - McAllen McAllen Texas 78503
Texas Oncology Plano East Plano Texas 75075-7787
Cancer Care Centers of South Texas San Antonio Texas 78217
Texas Oncology - Tyler Tyler Texas 75702
Virginia Oncology Associates Norfolk Virginia 23502
Puget Sound Cancer Center Seattle Washington 98133
Yakima Valley Memorial Hospital Yakima Washington 98902

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01421472, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 2, 2016 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01421472 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →